Team

Back to team overview

Partner

Dr. Regina Neuefeind

Partner

German Patent Attorney

European Patent Attorney

UPC Representative

Biologist

LL.M. "European Intellectual Property Law“

Regina advises and represents clients in securing, defending, enforcing and challenging intellectual property rights in Germany, Europe and around the world. Her main professional activities relate to the preparation of freedom-to-operate and validity opinions and due diligence analyses. She also represents clients in complex opposition, nullity and infringement proceedings in the fields of molecular biology, biochemistry, biotechnology and pharmaceuticals, with special focus on protein-based drugs and biosimilars as well as plant biotechnology.

„valuable input regarding FTOs, prosecution and oppositions” (client)

– JUVE Patent, 2021

T

+49 (0)89 747 266 0

F

+49 (0)89 776 424

E

Contact data VCF | Vita PDF

since 2001
Partner, shareholder and managing director at Maiwald
since 1999
Patent attorney at Maiwald
1996 - 1999
Patent attorney trainee at Maiwald

2023
Admitted to practice before the UPC
2004 - 2006
Master’s degree in „European Intellectual Property Law“ (LL.M.) from the University of Hagen with a focus on "European and International Civil Procedure Law" and "Patent Infringement and Nullity in England and France"
2001
Admitted to practice as European patent attorney
1999
Admitted to practice as German patent attorney
1996 - 1998
Studied law for patent attorneys at the University of Hagen
1995
Postdoc research work at the Max Planck Institute for Plant Breeding Research
1992 - 1994
Doctoral degree in biology from the University of Hohenheim (doctoral research at the Institute for Biotechnology of Bayer AG, Crop Science)
1991
Diploma thesis at the Institute for Genetics of the University of Cologne
1986 - 1990
Studied biology, biochemistry and pharmacology at the University of Cologne and the University of Sussex

  • Patent prosecution and portfolio management
  • Filing strategies and drafting patent applications
  • Supplementary protection certificates proceedings  
  • Freedom-to-operate and validity analysis
  • Opposition and nullity proceedings
  • Patent litigation
  • Strategic consulting for biosimilar development

  • Listed as best lawyer 2025 in Handelsblatt in the categories Biotechnology Law, Intellectual Property Law, Litigation
  • Recommended in Handelsblatt | Best Lawyers "Germany's Best Lawyers" 2020, 2021, 2022, 2023, 2024
  • "Recommended individual" in JUVE Patent Rankings - Germany 2021, 2022, 2023, 2024
  • Recommended in Legal 500 EMEA 2022
  • For many years listed as “frequently recommended lawyer” in the JUVE Handbuch Wirtschaftskanzleien

  • Representation in various opposition and appeal proceedings before the European Patent Office concerning blockbusters such as Humira®, Herceptin®, Mabthera®, Avastin®, Enbrel®, Stelara®, Keytruda®, Eylea®, Lucentis® and Dupixent®
  • Representation in opposition and appeal proceedings before the European Patent Office concerning biologics such as Neulasta®, Nplate®, RoActemra®, Prolia®, Hemlibra®, Saphnelo® and Simponi®

  • German Patent Attorney Association
  • epi
  • GRUR
  • FICPI

  • German
  • English